Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B
Richard S. Garfein, William A. Bower, Cherry M. Loney, Yvan J. F. Hutin, Guo‐Liang Xia, Jaspaul Jawanda, Amy V. Groom, Omana V. Nainan, James S. Murphy, Beth P. Bell – 7 March 2007 – Death related to acute hepatitis B occurs in approximately 1% of patients. We investigated an outbreak of hepatitis B virus (HBV) infections among injection drug users (IDUs) resulting in several deaths. We conducted a case‐control study of fulminant (case patients) and nonfulminant (control patients) HBV infections. We directly sequenced the entire HBV genome from fulminant and nonfulminant cases.